J K. Sethi
Affiliations: | Clinical Biochemistry | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"J Sethi"Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Eaton SA, Sethi JK. (2019) Immunometabolic Links between Estrogen, Adipose Tissue and Female Reproductive Metabolism. Biology. 8 |
| Sethi JK, Byrne CD. (2018) Nutritional Targeting of Cancer Cell Metabolism in Obesity. The Journal of Nutrition. 148: 1207-1208 |
| Nguyen-Tu MS, Nivoit P, Oréa V, et al. (2018) Inflammation-linked adaptations in dermal microvascular reactivity accompany the development of obesity and type 2 diabetes. International Journal of Obesity (2005) |
| Patel MN, Bernard WG, Milev NB, et al. (2015) Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation. Proceedings of the National Academy of Sciences of the United States of America. 112: 506-11 |
| Robinson KA, Hegyi K, Hannun YA, et al. (2014) Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes. Plos One. 9: e108963 |
| Carobbio S, Hagen RM, Lelliott CJ, et al. (2013) Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes. 62: 3697-708 |
| Hu CZ, Sethi JK, Hagen T. (2012) The role of the cullin-5 e3 ubiquitin ligase in the regulation of insulin receptor substrate-1. Biochemistry Research International. 2012: 282648 |
| Virtue S, Feldmann H, Christian M, et al. (2012) A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization. Diabetes. 61: 3139-47 |
| Virtue S, Masoodi M, Velagapudi V, et al. (2012) Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo. Plos One. 7: e39512 |
| Rajwani A, Ezzat V, Smith J, et al. (2012) Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes. 61: 915-24 |